
Purnendu Chatterjee is aiming big once again. This time it8217;s Europe. The Haldia Petrochemicals co-promoter is making a bid for Dutch petrochemicals giant Basel Polyolefins in consortium with leading Indian private equity fund ICICI Ventures and a host of US-based investors. The 4 billion euro estimated at over Rs 22,000 crore bid, would clearly be the largest one ever originating from Indian shores till date. The consortium aims to buy 100 per cent of the Dutch firm, whose current owners Royal Dutch/ Shell Group and German major BASF AG would be exiting the business to focus on their core operations. Chatterjee, the forward-looking tycoon, is clearly targeting the acquisition of the leading technologies that this 5.7 billion euro major owns in the field of polyolefins. However, in view of the deal8217;s big size, Purnendu and ICICI would only be picking minority stakes in the company, leaving the majority for the yet unidentified US-based funds. The tycoon8217;s ambitious bid, if pulled through, would certainly dwarf the mega acquisitions concluded by Indian companies recently, be it the 1.7 billion that ONGC Videsh paid for the 20 per cent stake in the Shakhalin oilfield or for that matter Tata8217;s 300 million deal for Tetley or Tata Steel8217;s 280-290 million deal for Singapore8217;s Nat Steel.
Dining at the pumps
Reddy8217;s best on its way
K. Anji Reddy has acquired a drug for the home market like no other. The tycoon will soon start the trials of this drug, that has the wonderful power of protecting cancer patients against the side-effects of radiation therapy. For this, a generous amount of Rs 2 crore has been kept aside. This drug was incidentally developed by two institutes of the Defence Research and Development Organisation DRDO 8212; one in Gwalior and the other in New Delhi 8212; from where the technology has been transferred to the tycoon8217;s labs in exchange for Rs 25 lakh and a royalty of 5 per cent. The drug ensures that only cancer cells are destroyed and protects normal ones. Thus undesirable side-effects like nausea, hair-loss, loss of appetite etc does not occur. While the world of cancer therapy is waiting to rock with Reddy8217;s drug, wonder what the tycoon will bring out next.
dilipcherianhotmail.com